Program Updates

top of page

Praetego’s PTG-630 Successfully Completes a Pre-IND Meeting with the FDA’s Division of Neurology

Praetego

Dec 14, 2023

PROGRAM UPDATES

Praetego’s PTG-630 Successfully Completes a Pre-IND Meeting with the FDA’s Division of Neurology

Praetego successfully completed a Pre-IND meeting with the FDA’s Division of Neurology for PTG-630

Press + Announcements

Praetego’s progress is routinely updated as we strive to enter clinical trials. Please check back frequently for news, announcements, and events.

bottom of page